Related Experiment Video
Updated: Apr 27, 2026

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
Interventional therapies for malignant pleural effusions: the present and the future
Rajesh Thomas1, Roslyn Francis, Helen E Davies
1Department of Respiratory Medicine, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia; School of Medicine and Pharmacology, University of Western Australia, Perth, Western Australia, Australia; Pleural Disease Unit, Lung Institute of Western Australia, Perth, Western Australia, Australia.
Management of malignant pleural effusions (MPE) now prioritizes patient-reported outcomes and less invasive treatments like indwelling pleural catheters (IPCs). Current challenges include understanding breathlessness and predicting treatment success for MPE.
Area of Science:
- Pulmonology
- Oncology
- Interventional Procedures
Background:
- Malignant pleural effusions (MPE) management has evolved, shifting focus from aggressive surgery to minimally invasive techniques.
- Patient-reported outcomes are now the primary goal, guiding clinical trials and treatment strategies for MPE.
Purpose of the Study:
- To review current interventional procedures for malignant pleural effusion (MPE) management.
- To discuss controversies, limitations, and future research needs in MPE care.
Main Methods:
- Overview of therapeutic thoracentesis, pleurodesis (including talc), and indwelling pleural catheter (IPC) drainage.
- Discussion of recent studies on IPC effectiveness and safety.
- Identification of challenges in MPE management, such as predicting outcomes.
Main Results:
- Therapeutic thoracentesis offers temporary relief; pleurodesis is definitive but faces efficacy/safety challenges.
- Indwelling pleural catheters (IPCs) are increasingly accepted for symptom improvement without guaranteed pleural symphysis.
- Recent data support IPC effectiveness and safety in MPE management.
Conclusions:
- Choosing optimal MPE intervention remains challenging due to limited understanding of breathlessness and lack of outcome predictors.
- Further research is needed to improve MPE management, focusing on patient outcomes and personalized treatment selection.
- Less invasive methods are replacing older surgical approaches for MPE.
Related Concept Videos
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Flail Chest-II
Assessment:
1. Clinical Evaluation:
History:
Pleural Disorders: Types and Brief Description
Endoscopic Studies II: Thoracocentesis
Description
Excess pleural fluid or air may accumulate in some respiratory disorders in the thoracic cavity. To treat pleural effusion, a physician conducts thoracentesis by carefully piercing the chest wall and entering...
Pneumothorax-II
Clinical Manifestations:

